Talasemi Majör ve İntermedialı Çocuklarda Serum Prohepsidin Düzeyleri

Amaç: Talasemi majör (TM) ve talasemi intermedialı (Tİ) hastalarda hepsidin hormonunun öncülü olan prohepsidin düzeyleri incelenerek bu hormonun demir birikimindeki rolünü değerlendirmektir. Gereç ve Yöntemler: Adnan Menderes Üniversitesi Tıp Fakültesi, Çocuk Hematoloji Anabilim Dalı ve Aydın Atatürk Devlet Hastanesi'nde 1 Eylül 2006 ve 30 Eylül 2007 tarihleri arasında izlenen ve enfeksiyon, enflamasyon, hepatit ve karaciğer yetmezliği olmayan 34 TM, 10 Tİ'li hastada ve 40 sağlıklı kontrol grubunda serum prohepsidin ve serum ferritin düzeyine bakıldı. Ferritin, Immulite 2000 cihazında kemilüminesans yöntemiyle, prohepsidin DRG International, Inc. Marburg, Germany kiti kullanılarak ELISA yöntemiyle çalışıldı.Bulgular: Ortalama serum ferritin düzeyleri TM, Tİ ve kontrol grubunda sırasıyla 2347,97±1724,81 ng/mL (dağılım, 144-8015 ng/mL), 1352,40±918,94 ng/mL.

Serum Prohepcidin Levels in Children with Thalassemia Major and Intermedia

Objective: To determine the role of hepcidin hormone levels in iron accumulation in patients with thalassemia major (TM) and thalassemia intermedia (TI).Materials and Methods: Serum prohepcidin and ferritin levels were determined in 34 patient with TM, 10 patient with TI, who attended the Department of Pediatric Hematology Adnan Menderes University Medical Faculty and the Department of Pediatrics at Aydın Atatürk State Hospital between 1 September 2006 and 30 September 2007 and 40 control patients without infection/inflammation, hepatitis or liver failure. Serum prohepcidin levels were measured using a commercial enzymelinked immunosorbent assay kit (DRG International, Inc. Marburg, Germany); ferritin was studied with chemiluminescence method (Immulite 2000 DPC).Results: Mean serum ferritin levels in TM, TI and control groups were 2347.97±1724.81 ng/mL (range: 144-8015 ng/mL), 1352.40±918.94 ng/mL (range: 311-3109 ng/mL), and 33.35±12.03 ng/mL (range: 20-69.1 ng/mL), respectively. Serum prohepcidin levels in the same groups were 221.78±74.38 ng/mL (range: 7l.14-446.57 ng/mL), 173.31±52.14 ng/mL (range: 100.83-267.69 ng/mL), and 218.20±50.37 ng/mL (range: 116.18-330.43 ng/mL), respectively. There was a statistically significant difference in prohepcidin levels between patients with TI and control group only (p=0.016). No correlation was found between prohepcidin and ferritin levels in all groups (r=-0.023, p=0.839).Conclusion: Low levels of prohepcidin in patients with TI may be related to increased erythropoietic activity. Prohepcidin can be an indicator of active erythropoiesis.

___

  • 1. Saliba AN, Harb AR, Taher AT. Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions. Blood Med 2015; 6: 197-209.
  • 2. Gardenghi S, Grady RW, Rivella S. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in ?-thalassemia. Hematol Oncol Clin North Am 2010; 24: 1089-107.
  • 3. Taher A, Hershko C, Cappellini MD. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies. Br J Haematol 2009; 147: 634-40.
  • 4. Nemeth E. Hepcidin and ?-thalassemia major. Blood 2013; 122: 3-4.
  • 5. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep 2015; 35: 1-12.
  • 6. Kim A, Nemeth E. New insights into iron regulation and erythropoiesis. Curr Opin Hematol 2015; 22: 199-205.
  • 7. Musallam KM, Cappellini MD, Wood JC, Taher AT. Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev 2012; 26(Suppl 1): S16-9.
  • 8. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 2002; 99: 4596-601.
  • 9. Frazer DM, Inglis HR, Wilkins SJ, Millard KN, Steele TM, McLaren GD, et al. Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 2004; 53: 1509-15.
  • 10. Uysal Z. Hepsidin ve demir metabolizması. 33. Ulusal hematoloji kongresi kitabı, Ankara, 2007; 9-15.
  • 11. Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, et al. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut 2004; 53: 735-43.
  • 12. Kattamis A, Papassotiriou I, Palaiologou D, Galani FAA, Ladis V, Sakellaropoulos N, et al. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 2006; 91: 809-12.
  • 13. Adamsky K, Weizer O, Amariglio N, Breda L, Harmelin A, Rivella S, et al. Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 2004; 124: 123-4.
  • 14. Franceschi LD, Daraio F, Filippini A, Carturan S, Muchitsch EM, Roetto A, et al. Liver expression of hepcidin and other iron genes in two mouse models of beta thalassemia. Haematolgica 2006; 91: 336-42.
  • 15. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 2006; 55: 667-74.
  • 16. Camberlein E, Zanninelli G, Detivaud L, Lizzi AR, Sorrentino F, Vacquer S, et al. Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression. Haematologica 2008; 93: 111-5.
  • 17. Weizer-Stern O, Adamsky A, Amariglio N, Rachmilewitz E, Breda L, Rivella S, et al. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am J Hematol 2006; 81: 479-83.
  • 18. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood 2005; 105: 4103-5.
  • 19. Roe MA, Spinks C, Heath AL, Harvey LJ, Foxall R, Wimperis J, et al. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with ironstatus in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Br J Nutr 2007; 97: 544-9.
  • 20. Ezeh C, Ugochukwu CC, Weinstein J, Okpala I. Hepcidin, haemoglobin and ferritin levels in sickle cell anaemia. Eur J Haematol 2005; 74: 86-8.
  • 21. Ulukol B, Orhon FS, Hanoluk A, Akar N. Serum pro-hepcidin levels and relationship with ferritin in healthy non-anaemic infants. Acta Haematol 2007; 118: 70-2. Epub 2007 May 24.
  • 22. Tsuchihashi D, Abe T, Kobama H, Fujii H, Hamada Y, Nii-Kono T, et al. Serum prohepcidin as an indicator of iron status in dialysis patients. Ther Apher Dial 2008; 12: 226-31.
  • 23. Kijima H, Sawada T, Tomosugi N, Kubota K. Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma. BMC Cancer 2008; 8: 67.
Meandros Medical And Dental Journal-Cover
  • ISSN: 2149-9063
  • Başlangıç: 2000
  • Yayıncı: Erkan Mor
Sayıdaki Diğer Makaleler

ST Segment Yükselmesine Neden Olan Akut Perikardit

Şükrü Gürbüz MD, Seval Demir AYDIN, MUHAMMET GÖKHAN TURTAY, ŞÜKRÜ GÜRBÜZ, HASAN PEKDEMİR, HAKAN OĞUZTÜRK, Taner GÜVEN

Endodontide Dental Lazerler ve Uygulama Alanları Endodontics

Emrah Çetin MD, EMRAH ÇETİN, Hicran Dönmez ÖZKAN, SENEM GÖKÇEN YİĞİT ÖZER

Fibromiyalji Sendromu Olan Hastalarda Kronik Periodontitis, Bruksizm ve Temporamandibular Eklem Rahatsızlığı Prevalansı

Özge Göktürk MD, HATİCE BALCI YÜCE, Ahmet İNANIR, ÖZGE GÖKTÜRK, Hümeyra Aydemir TURKAL, VİLDAN BOSTANCI

Hiperamilazeminin Nadir Bir Nedeni: Makroamilazemi

Adil Coşkun MD, Adil COŞKUN, Deniz ÇETİN, M. Hadi YAŞA, A. Önder KARAOĞLU

Kafa Travmasında Kafa İçi Basınç ve Hipotalamo-Hipofizer- Gonadal Aks Arasındaki İlişkinin Değerlendirilmesi

Mücahit Avcil MD, ALİ YILMAZ, MÜCAHİT AVCİL, ZAHİR KIZILAY, Kubilay Murat ÖZDENER, Bayram ÇIRAK, Kadir TAHTA

Talasemi Majör ve İntermedialı Çocuklarda Serum Prohepsidin Düzeyleri

Celil YILMAZ, YUSUF ZİYA ARAL, ASLIHAN BÜYÜKÖZTÜRK KARUL, LEYLA DİDEM KOZACI

Maksiller Orta Hat Diastemasının Hareketli Şeffaf Plak ve Elastikler Kullanılarak Tedavisi: Olgu Sunumu

Kadir Beycan MD, Sümeyya ŞİN, Kadir BEYCAN, Yazgı AY

The Characteristics of Patients Transferred by Helicopter Ambulance in Erzurum

Sultan Tuna GÜR AKGÖL, ATIF BAYRAMOĞLU, HÜSEYİN ŞAHİN

Sternoclavicular Joint: A Case Report Primary Tuberculosis of the Sternoclavicular Joint: A Case Report

Ebru ATALAR, Şerife Nilgün KALAÇ, Sadi KAYA, Mehtap AYDIN

Rastlantısal Bir Bulgu Olarak Maksiller Lateral Dişlerde Dens İnvajinatus, Tanı ve Tedavide Konik Işınlı Bilgisayarlı Tomografinin Rolü

Emre Köse MD, EMRE KÖSE, DUYGU GÖLLER BULUT, Özge ULUSAN